Palm Beach Gardens, FL – (July 24, 2012) – Preservation of hard and soft tissues around a dental implant is key to achieving long-term sustainable aesthetic outcomes for the patient. As part of its commitment to provide clinicians with treatment solutions for achieving sustainable aesthetics, BIOMET 3i announced today that recent research demonstrates how specific features of the PREVAIL Implant System are designed for preservation.
The research demonstrates:
Crestal bone preservation through the PREVAIL Implant’s integrated platform switching feature; optimizing patient aesthetics with as little as 0.37mm of bone recession1 and 50% reduction in crestal bone remodeling vs. non platform-switched implants2 Soft-tissue protection through the PREVAIL Implant’s unique Certain® Internal Connection design; providing 45% higher connection strength and 50% higher seal strength as compared to three competitor averages3
Enhanced osseointegration with OSSEOTITE® and NanoTiteTM PREVAIL Implants; two implant systems designed for primary stability with surface topographies targeting bone apposition and early healing. Additionally, research shows peri-implantitis risk mitigation with the OSSEOTITE surface4
1. Östman PO†, Wennerberg A, Albrektsson T. Immediate occlusal loading of NanoTite Prevail Implants: A prospective 1-year clinical and radiographic study. Clin Implant Dent Relat Res. 2010 Mar;12(1):39–47.
2. Boitel N, Andreoni C, Grunder U†, Naef R, Meyenberg, K. A three year prospective, multicenter, randomized-controlled study evaluating platform- switching for the preservation of peri-implant bone levels. Poster presentation P83: Academy of Osseointegration, 26th Annual Meeting: 2011 March 3–5; Washington DC.
3. Baumgarten H†, Meltzer A†. Improving outcomes while employing accelerated treatment protocols within the aesthetic zone: From single tooth to full arch restorations. Presented at the Academy of Osseointegration, 27th Annual Meeting; March 2012; Phoenix, AZ.
4. Zetterqvist L, et al. A Prospective, Multicenter, Randomized-controlled Five-year Study of Hybrid and Fully-etched Implants for the Incidence of Peri-implantitis. J Periodontol. 2010 Apr;81(4):493-501.
†Aforementioned have financial relationships with BIOMET 3i LLC resulting from speaking engagements, consulting engagements and other retained services.
About BIOMET 3i BIOMET 3i LLC is a leading manufacturer of dental implants, abutments and related products. Since its inception in 1987, BIOMET 3i has been on the forefront in developing, manufacturing and distributing oral reconstructive products, including dental implant components and bone and tissue regenerative materials. The company also provides educational programs and seminars for dental professionals around the world. BIOMET 3i is based in Palm Beach Gardens, Florida, with operations throughout North America, Latin America, Europe and Asia-Pacific. For more information about BIOMET 3i, please visit www.biomet3i.com or contact the company at (800) 342-5454; outside the U.S. dial (561) 776-6700.